Calendar
| Hi Everyone,
We want to quickly get to right to it because there is no telling how long this stock will remain under wraps! Our BRAND NEW announcement = USNU USNU has had NO activity in quite awhile now. It looks like Wall Street has no idea that USNU even exists, which could be great for our subscribers as this could represent a ground floor opportunity! USNU is currently trading at: $0.14 The Company is involved with something HUGE! Most of you have probably heard about gamma knife surgery before. This is a major advance that has revolutionized the field of neurosurgery. USNU owns and operates stereotactic radiosurgery centers that utilize the gamma knife technology and has been doing this for over a decade now. It’s kind of crazy to us that a Company involved with something so monumental in the medical industry could only be trading at 14 cents! THIS IS A REVOLUTIONARY BREAKTHROUGH IN BRAIN SURGERY TECHNOLOGY! Gamma Knife treatment is a type of radiation therapy used to treat tumors and other abnormalities in the brain. Don’t let the name fool you, there is no knife involved. Specialized equipment focuses as many as close to 200 tiny beams of radiation on a tumor or other target. One of the best advantages with this kind of treatment is that it does not involve multiple visits to the hospital and the patient does not incur operating room or post-operative intensive care costs. This means it is generally considered to be a COST EFFECTIVE alternative to conventional brain surgery for certain types of cases. The treatment is even covered by most insurance plans! This method of radiosurgery is the most dramatic advance in brain surgery in decades and has helped to change the landscape of neurosurgery. There are some variations and other modalities of similar treatment, yet Gamma Knife is recognized as the GOLD STANDARD!
ABOUT GAMMA KNIFE TECHNOLOGY: The Gamma Knife, a remarkable, 20 ton medical device, was invented in 1968 by a Swedish duo, Dr. Lars Leksell of Karolinska Institute and biophysicist Professor Borje Larsson. Gamma Knife radiosurgery is not intended to replace conventional neurosurgery, but it is an effective, additional weapon to combat vascular malformations and tumors of the brain. The treatment may serve as an adjunct to standard neurosurgical therapy or as the preferred course of treatment when traditional surgery is not recommended. The Gamma Knife allows noninvasive cerebral surgery to be performed with accuracy and precision sparing healthy tissue adjacent to the treated site. It is painless, bloodless and requires usually no overnight stay. Check out this YouTube video of Scott Hamilton talking about his experience with Gamma Knife surgery: http://www.youtube. Brain surgery without an incision! It’s remarkable really. The Gamma Knife has been in use in the United States for more than two decades, providing patients with a treatment option for brain disorders that were once only treatable by open skull surgery. Recent advances in neuro-imaging techniques and the increasing power of computers have been responsible for the rapid growth of radiosurgery in recent years. Many years of well-documented research and clinical evaluation support the efficacy of Gamma Knife technology. Over half a million patients have been treated with Gamma Knife surgery. In fact, Gamma Knife is the ONLY radiation therapy system specifically licensed by the FDA for irradiating brain metastases. With unsurpassed and proven clinical outcomes, the Gamma Knife is the gold standard in cranial radiosurgery. (http://socalgammaknife.org/)
ABOUT THE COMPANY: USNU owns and operates a gamma knife center on the premises of New York University Medical Center in New York, New York; and has ownership interest in the Southern California Regional Gamma Knife Center at the San Antonio Community Hospital in Upland, California. USNU markets to medical centers, physicians, and other health care providers seeking a well financed, experienced partner for technology-driven medical services ventures. In USNU’s twenty five year history in the health care business, they have successfully developed ventures in medical software, capitated specialty networks, managed care, web-based pharmacy, reproductive endocrinology systems, women’s wellness centers and substance abuse treatment centers. More information on USNU can be found here: http://www.usneuro.com/
THE MARKET: There is a significant market out there for USNU’s stereotactic radiosurgery centers. Gamma Knife surgery is recognized worldwide as the PREFERRED TREATMENT for brain tumors both benign and malignant as well as for functional diseases of the brain such as: arteriovenous malformations, trigeminal neuralgia, tremors and Parkinson’s disease. In Parkinson’s disease, the tremor or shaking usually involves the arms and hands and is most prominent when the patient is at rest. Tremors can sometimes involve the head and neck and also sometimes involves the legs. Tremor interferes with many normal activities. Parkinson’s disease affects over 1.5 million Americans with 60,000 new cases being diagnosed each year! The Gamma Knife can sometimes relieve the uncontrollable tremors for those who suffer from Parkinson’s disease.
Top 3 Reasons to look at USNU RIGHT NOW:
Check out American Shared Hospital Services (AMS), a comparison in today’s market – it’s trading at over $3.00 a share!
Put USNU on your RADAR right away!! There’s no telling how much longer USNU may remain hidden from Wall Street!! We are issuing a VERY STRONG ALERT right now!! Sincerely, The Penny Stocks Profile Team |
 |
6526 south kanner highway suite 214, stuart, FL 34997, USA
